CNFG
CVS icon

Creegan & Nassoura Financial Group’s CVS Health CVS Stock Holding History

Creegan & Nassoura Financial Group’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-24,302
Closed -$1.83M – 79
2025
Q3 		$1.83M Sell
24,302
-890
-4% -$61K 1.18% 34
2025
Q2 		$1.74M Sell
25,192
-5,185
-17% -$340K 1.13% 33
2025
Q1 		$2.06M Hold
30,377
– – 1.37% 31
2024
Q4 		$1.36M Sell
30,377
-5,264
-15% -$295K 0.92% 40
2024
Q3 		$2.24M Sell
35,641
-790
-2% -$46.1K 1.41% 31
2024
Q2 		$2.15M Hold
36,431
– – 1.48% 27
2024
Q1 		$2.91M Hold
36,431
– – 1.94% 14
2023
Q4 		$2.88M Buy
36,431
+4,583
+14% +$326K 2.09% 15
2023
Q3 		$2.22M Sell
31,848
-200
-0.6% -$14.2K 1.73% 21
2023
Q2 		$2.22M Hold
32,048
– – 1.64% 26
2023
Q1 		$2.38M Buy
32,048
+7,731
+32% +$648K 1.83% 20
2022
Q4 		$2.27M Hold
24,317
– – 1.77% 20
2022
Q3 		$2.32M Hold
24,317
– – 2.01% 18
2022
Q2 		$2.25M Sell
24,317
-250
-1% -$24.4K 1.89% 20
2022
Q1 		$2.49M Sell
24,567
-60
-0.2% -$6.3K 1.86% 22
2021
Q4 		$2.54M Sell
24,627
-300
-1% -$27.7K 1.92% 20
2021
Q3 		$2.12M Sell
24,927
-100
-0.4% -$8.38K 1.8% 21
2021
Q2 		$2.09M Sell
25,027
-800
-3% -$65.5K 1.79% 23
2021
Q1 		$1.94M Sell
25,827
-850
-3% -$61.9K 1.73% 24
2020
Q4 		$1.82M Sell
26,677
-100
-0.4% -$6.5K 1.75% 25
2020
Q3 		$1.56M Hold
26,777
– – 1.68% 27
2020
Q2 		$1.74M Sell
26,777
-1
-0% -$63 1.96% 20
2020
Q1 		$1.59M Hold
26,778
– – 2.07% 17
2019
Q4 		$1.99M Buy
+26,778
New +$1.88M 2% 18
2016
Q1 		– Sell
-2,439
Closed -$238K – 75
2015
Q4 		$238K Hold
2,439
– – 0.27% 72
2015
Q3 		$235K Hold
2,439
– – 0.27% 72
2015
Q2 		$256K Hold
2,439
– – 0.27% 69
2015
Q1 		$252K Hold
2,439
– – 0.26% 72
2014
Q4 		$235K Buy
+2,439
New +$215K 0.24% 72

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Creegan & Nassoura Financial Group's CVS Position: Q4 2025 in Review

Creegan & Nassoura Financial Group sold out of CVS Health (CVS) in Q4 2025, closing a stake of 24,302 shares — an estimated $1.83M sold.

Creegan & Nassoura Financial Group first reported a position in CVS in Q4 2014 and held it in 29 quarters. The position peaked at $2.91M in Q1 2024. 1,946 funds tracked by Wall St. Rank hold CVS as of Q4 2025.

  • Creegan & Nassoura Financial Group reported no remaining CVS Health position as of Q4 2025 after selling out during the quarter.
  • Creegan & Nassoura Financial Group sold 24,302 CVS Health shares in Q4 2025, an estimated $1.83M.
  • Creegan & Nassoura Financial Group first reported a position in CVS Health in Q4 2014 and held it in 29 quarters.
  • Creegan & Nassoura Financial Group's CVS Health position peaked at $2.91M in Q1 2024.
  • 1,946 funds tracked by Wall St. Rank held CVS Health as of Q4 2025.

Based on Creegan & Nassoura Financial Group's 13F filing for Q4 2025, filed 17 Feb 2026.